Vivtex originated from MIT, with a mission to enable the development of new oral drugs using sophisticated high throughput screening technologies, IP protected formulation libraries and molecular modeling/AI techniques. Vivtex has R&D collaborations with leading biotechnology and pharmaceutical companies with several oral peptide programs at the pre-clinical to clinical stage. Our vision is to empower patients with a choice of how to take their medicine.
| Website | http://www.vivtex.com |
| Revenue | $2 million |
| Employees | 23 (18 on RocketReach) |
| Founded | 2018 |
| Address | 135 William T Morrissey Blvd Suite P101, Boston, Massachusetts 02125, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+5 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Drug Discovery, Drug Development, Organ On A Chip, Platform Technology, Biotechnology, Pharmaceutical Research, Biomedical Technology, Pharmaceutical Technology, Organ Preservation, Preclinical Testing, Drug Testing, Biosensors, Medical Devices, Robotic Systems |
| Competitors | Interface, Milliken & Company, Desso, Mohawk Industries, Shaw Floors, HANESBRANDS INC, Carpets International Thailand PCL., BASF, DUCHATEAU, Strudex Fibres Limited +23 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Vivtex employee's phone or email?
The Vivtex annual revenue was $2 million in 2026.
Thomas von Erlach is the Co-Founder and CEO of Vivtex.
18 people are employed at Vivtex.
Vivtex is based in Boston, Massachusetts.
The NAICS codes for Vivtex are [325, 32, 32541, 3254].
The SIC codes for Vivtex are [283, 2834, 28].